NCDC flags study on rising antibiotic resistance in India, Pg12

Key Highlights:

• The National Centre for Disease Control (NCDC) has challenged the findings of a Lancet study that claimed over 50% of Indian patients undergoing ERCP are colonized with multi-drug-resistant organisms (MDRO).
• The Lancet study described rising antimicrobial resistance in India as a rapidly escalating superbug crisis and a global threat.
• The NCDC clarified that the study reported colonization of MDROs, not actual infections, and the results cannot be generalized to the entire Indian population.
• The research paper was published in The Lancet's journal eClinicalMedicine.

Detailed Insights:

• The Lancet study focused on patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), a procedure used to diagnose and treat issues in the gallbladder, bile ducts, and pancreas.
• Colonization refers to the presence of MDROs in the body without causing active infection or clinical symptoms.
• The NCDC is responsible for preventing, detecting, and controlling diseases of public health importance in India, and it plays a crucial role in monitoring and addressing antimicrobial resistance.
• Antimicrobial resistance is a growing global concern that threatens the effectiveness of antibiotics and other antimicrobial drugs, potentially leading to increased morbidity and mortality.

Key Concepts Involved:

• Antimicrobial Resistance (AMR): The ability of microorganisms to resist the effects of antimicrobial drugs, making infections harder to treat.
• Multi-Drug-Resistant Organisms (MDRO): Microorganisms that are resistant to multiple antibiotics, posing a significant challenge to treatment.
• Colonization: The presence of microorganisms in or on the body without causing infection or symptoms of disease.